← All companies

INNP

InnoCan Pharma Corporation

INNPF Pharmaceutical Preparations EDGAR ↗

$1.90

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.60 – $14.26

Recent SEC filings

31 most recent

Other filings

FWP Apr 3, 2026 F-1/A Apr 3, 2026 FWP Mar 16, 2026 F-1 Mar 16, 2026 RW Feb 23, 2026 EFFECT Jan 30, 2026 F-1/A Jan 7, 2026 FWP Jan 6, 2026 F-1/A Jan 6, 2026 8-A12B/A Dec 22, 2025 8-A12B/A Dec 19, 2025 8-A12B/A Dec 16, 2025 FWP Dec 10, 2025 F-1/A Dec 10, 2025 DEL AM Nov 10, 2025 F-1/A Oct 22, 2025 FWP Oct 1, 2025 F-1/A Sep 30, 2025 8-A12B Sep 22, 2025 FWP Sep 12, 2025 FWP Sep 5, 2025 F-1/A Sep 5, 2025 F-1/A Aug 4, 2025 F-1 Jul 23, 2025 DRS/A Jun 20, 2025 DRS/A May 15, 2025 DRS/A May 12, 2025 DRS/A May 1, 2025 DRS/A Mar 28, 2025 DRS Dec 31, 2024 D Item 06b Oct 26, 2021